4-aminobenzoyl-glycyl-prolyl-leucyl-alanine hydroxamic acid has been researched along with Apoplexy in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cybulska-Klosowicz, A; Kossut, M; Liguz-Lecznar, M; Nowicka, D; Skangiel-Kramska, J; Ziemka-Nalecz, M | 1 |
1 other study(ies) available for 4-aminobenzoyl-glycyl-prolyl-leucyl-alanine hydroxamic acid and Apoplexy
Article | Year |
---|---|
Matrix metalloproteinase inhibition counteracts impairment of cortical experience-dependent plasticity after photothrombotic stroke.
Topics: Animals; Autoradiography; Brain Mapping; Carbon Radioisotopes; Deoxyglucose; Hydroxamic Acids; Matrix Metalloproteinase Inhibitors; Matrix Metalloproteinases; Mice; Mice, Inbred C57BL; Neuronal Plasticity; Oligopeptides; Radionuclide Imaging; Sensory Deprivation; Somatosensory Cortex; Stroke; Vibrissae | 2011 |